Market Tracker

10/31 7:05pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

55.27
Data as of Oct 31
 +0.90 / +1.66%
Today’s Change
41.99
Today|||52-Week Range
80.42
+5.08%
Year-to-Date

Today’s Trading

Previous close54.37
Today’s open55.60
Day’s range54.80 - 57.32
Volume359,983
Average volume (3 months)447,980
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+70.74%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio153.5
Price/Sales21.82
Price/Book22.43

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...-0.20-1.67%
CMRXChimerix Inc+1.15+3.85%
TSROTESARO Inc-0.88-3.07%
SGNTSagent Pharmaceutica...-0.26-0.82%
Data as of 3:59pm ET, 10/31/2014

Financials

Last reporting dateOctober 27, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts